title: Evaluation of multicomponent non-viral vectors for liver directed gene delivery.
abstract: Multicomponent, non-viral gene delivery vehicles are designed to have as a minimum, a DNA binding component, and a cell recognition component for specific delivery to target cells. The DNA binding component cannot only bind, but also protect DNA from serum degradation, and tends to condense DNA to sizes that can be taken up by receptor-mediated processes of target cells. Generally, cationic peptides, single chained, e.g. poly-L-lysine or branched polymers or synthetic peptides with DNA binding properties are used for DNA binding components. Ligands for binding to receptors on cell surfaces can be covalently linked to the DNA binding component. Multicomponent, non-viral vectors have been successfully used to deliver genes into cells in vitro and in vivo. Improvements have been made to the non-viral carriers resulting in increased solubility of DNA/carrier complexes and longer survival in serum. Improvements have also been made by incorporating fusogenic/lysosomolytic components that enable DNA/carrier complexes to escape intracellular degradation and enhance the levels and duration of expression of genes in vitro and in vivo.
authors.affiliation: Department of Medicine, University of Connecticut School of Medicine, Farmington 06030-1845, USA. cwu@nsol.uchc.ed
authors.forename: Catherine H
authors.initials: CH
authors.lastname: Wu
authors.forename: Eugene
authors.initials: E
authors.lastname: Sapozhnikov
authors.forename: George Y
authors.initials: GY
authors.lastname: Wu
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000379:methods; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage*; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000378:metabolism*